EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Miguel A. Castro
José L. Pomar
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mestres, C.-A.
Right arrow Articles by the Hospital Clinic Endocarditis Study Group
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mestres, C.-A.
Right arrow Articles by the Hospital Clinic Endocarditis Study Group,
Related Collections
Right arrow Cardiac - other

Eur J Cardiothorac Surg 2003;23:1007-1016
© 2003 Elsevier Science NL


Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1)

Carlos-A. Mestresa*, Javier E. Chuquiurea, Xavier Claramonteb, Josefa Muñozc, Natividad Benitob, Miguel A. Castroa, José L. Pomara, José M. Mirób, the Hospital Clinic Endocarditis Study Group

a Department of Cardiovascular Surgery, Hospital Clínico, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
b Infectious Diseases Service-Institut Clinic Infeccions Inmunologia (ICII), Hospital Clínic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
c Hospital de Basurto, Bilbao, Spain

Received 27 October 2002; received in revised form 10 March 2003; accepted 11 March 2003.

* Corresponding author. Tel.: +34-93-227-5515; fax: +34-93-451-4898
e-mail: cmestres{at}clinic.ub.es

Objectives: Assessment of long-term results of immunodeficiency virus type-1 (HIV-1)-infected patients undergoing cardiac surgery. Methods: Retrospective analysis of profile and outcomes of 31 HIV-1-infected patients (35 operations, 1985–2002). Results: Twenty-seven males and four females (mean age 34.67) in three groups: acute infective endocarditis (AIE) 21 (67.74%), coronary (CAD) 5 (16.13%) and non-infective valvular disease (NIVD) 5 (16.13%). HIV factors: drug addiction (23–74.19%), homosexuality (5–16.12%), heterosexuality (3–9.67%), hemodialysis (1–3.22%). HIV stage: A (17), B (2), C (2) in AIE; A (2), B (3) in CAD and A (3), C (2) in NIVD. Mean preoperative CD4 count was 278 cells/µL (12<200 cells/µL, 38.7%). The most frequent pathogens: S. aureus (52.38%), S. viridans (23.8%), Candida (19.04%). Native valve involved in 22 cases (78.33%) and prostheses in 8 (26.67%); 8.57% were operated in 1980–1985, 14.28% in 1986–1990, 22.85% in 1991–1995 and 54.28% in 1996–2002 with 16 elective (48.17%), 17 urgent (45.71%) and two emergencies (5.71%); mean aortic clamping and cardiopulmonary bypass time 78.9 and 107.47 min. Hospital mortality was 22.58 and 28.57% in AIE. No CAD patient died. Nine patients (37.5%) died between 2 and 171 months (mean 54.5). Mortality was 50% in AIE. CD4 count increased from 185.33 to 396.55 cells/µL (P=0.43) in nine patients on antiretrovirals. Fifteen-year actuarial survival is 58.16% overall and 48.01% for AIE. Conclusions: There is an increase in HIV-1-infected patients requiring cardiac surgery, a decrease in AIE, however NIVD and CAD increasingly seen. Cardiac surgery did not blunt CD4 response induced by antiretrovirals. The late cause of death were not AIDS-related events.

Key Words: Cardiac surgery • Human immunodeficiency virus • Endocarditis • Intravenous drug abusers • Homosexuality • Antiretroviral therapy




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
C.-A. Mestres
Acute hepatitis C virus and the cardiac surgeon: An explanation needed.
J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 1038 - 1038.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. A. Mestres, M. A. Castro, E. Bernabeu, M. Josa, R. Cartana, J. L. Pomar, J. M. Miro, J. Mulet, and the Hospital Clinico Endocarditis Study Group
Preoperative risk stratification in infective endocarditis. Does the EuroSCORE model work? Preliminary results
Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 281 - 285.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. Wahba and D. Nordhaug
What are the long-term results of cardiac valve replacements in left sided endocarditis with a history of i.v. drug abuse?
Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 608 - 610.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. M. Baddour, W. R. Wilson, A. S. Bayer, V. G. Fowler Jr, A. F. Bolger, M. E. Levison, P. Ferrieri, M. A. Gerber, L. Y. Tani, M. H. Gewitz, et al.
Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Circulation, June 14, 2005; 111(23): e394 - e434.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.